Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease

Agomelatine is a selective agonist of melatonin receptor 1A/melatonin receptor 1B (MT(1)/MT(2)) and antagonist of 5-hydroxytryptamine 2C receptors. It is used clinically to treat major depressive episodes in adults. The pro-chronobiological activity of agomelatine reconstructs sleep-wake rhythms and...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Qiang, Li, Tian, Liu, Guo-Wei, Zhang, Yan-Li, Guo, Jun-Hong, Wang, Zhao-Jun, Wu, Mei-Na, Qi, Jin-Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700086/
https://www.ncbi.nlm.nih.gov/pubmed/36204828
http://dx.doi.org/10.4103/1673-5374.353479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700086/
https://www.ncbi.nlm.nih.gov/pubmed/36204828
http://dx.doi.org/10.4103/1673-5374.353479

Ejemplares similares